Submitted by Anonymous (not verified) on 7 October 2026 - 14:50
Human medicines European public assessment report (EPAR): Lunsumio, mosunetuzumab, Date of authorisation: 03/06/2022, Revision: 9, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Lunsumio, mosunetuzumab, Date of authorisation: 03/06/2022, Revision: 9, Status: Authorised